A comment on innovation, growth and disruption in changing markets

Cogentum Blog

Ausmedtech Conference 2009

July 2nd, 2009 · 1 Comment

We presented recently (June 15th &16th) at the Australian Medical Technology conference held in Sydney. The conference brought together some of the regions leading firms and discussed a wide range of issues.

I was fortunate to present, in conjunction with David James from Invetech and Travis Hardy from ARRK on Design for Manufacturing and how many firms use DFM to drive their bottom lines. The highlight was the amazing outcomes being achieved by those companies who have adopted this process and incorporated it into everything they do.

You can see how the conference was covered in the press and by Manufacturers Monthly.

Nairy also presented on the Pathway to Commercialisation as part of a session on the challenges organisations face when bringing a new innovative technology to market. This was a great session and really highlighted the need for a consistent and common language that can be used by scientists, technologists, Business Development and Marketing. The end game is a solution that the market rapidly adopts and which can be made at a margin that rewards the management team and shareholders. 

If you would like a copy of either presentation please don’t hesitate to contact us.

Tags: Biotechnology · Organic Growth · Uncategorized · mature markets

1 response so far ↓

  • 1 Graeme Bullock // Aug 27, 2009 at 11:31 am

    It is great to see growing recognition that Great Design has no commercial value unless the product is easy to make. We take this approach in all our work, yet a surprising number of our new start-up customers are surprised by the effort to get manufacturing right that starts in the early design stages. The alternative to DFM is a very painful (=expensive), slow process of stop/start production lines and poor quality, that can kill companies.

Leave a Comment